Becton Dickinson and Co. (NYSE:BDX) declared a quarterly dividend on Monday, November 21st. Investors of record on Friday, December 9th will be paid a dividend of 0.73 per share on Friday, December 30th. This represents a $2.92 annualized dividend and a yield of 1.70%. This is a positive change from Becton Dickinson and’s previous quarterly dividend of $0.66.

Shares of Becton Dickinson and (NYSE:BDX) traded up 0.12% on Monday, reaching $172.07. The company had a trading volume of 896,767 shares. Becton Dickinson and has a 12 month low of $129.50 and a 12 month high of $181.76. The stock has a 50-day moving average price of $172.67 and a 200-day moving average price of $172.12. The stock has a market cap of $36.64 billion, a PE ratio of 38.32 and a beta of 1.04.

Becton Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $2.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.03. Becton Dickinson and had a return on equity of 24.44% and a net margin of 7.82%. The firm earned $3.23 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period last year, the company posted $1.94 EPS. The business’s quarterly revenue was up 5.6% on a year-over-year basis. Analysts predict that Becton Dickinson and will post $9.52 earnings per share for the current fiscal year.

Dividend History for Becton Dickinson and (NYSE:BDX)

In related news, insider Stephen Sichak sold 10,352 shares of the company’s stock in a transaction that occurred on Friday, November 4th. The stock was sold at an average price of $176.10, for a total value of $1,822,987.20. Following the transaction, the insider now owns 26,892 shares in the company, valued at $4,735,681.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of the company’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the completion of the transaction, the insider now owns 22,146 shares in the company, valued at approximately $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the stock. Jarislowsky Fraser Ltd increased its position in Becton Dickinson and by 1,050.3% in the second quarter. Jarislowsky Fraser Ltd now owns 10,373,430 shares of the company’s stock valued at $531,241,000 after buying an additional 9,471,594 shares during the last quarter. FMR LLC increased its position in Becton Dickinson and by 10.6% in the second quarter. FMR LLC now owns 2,923,810 shares of the company’s stock valued at $495,850,000 after buying an additional 279,101 shares during the last quarter. Parametric Portfolio Associates LLC increased its position in Becton Dickinson and by 30.9% in the second quarter. Parametric Portfolio Associates LLC now owns 628,240 shares of the company’s stock valued at $106,543,000 after buying an additional 148,292 shares during the last quarter. Panagora Asset Management Inc. increased its position in Becton Dickinson and by 1,074.3% in the second quarter. Panagora Asset Management Inc. now owns 158,815 shares of the company’s stock valued at $26,933,000 after buying an additional 145,291 shares during the last quarter. Finally, Martingale Asset Management L P increased its position in Becton Dickinson and by 80.1% in the second quarter. Martingale Asset Management L P now owns 254,195 shares of the company’s stock valued at $43,110,000 after buying an additional 113,020 shares during the last quarter. Institutional investors and hedge funds own 82.68% of the company’s stock.

BDX has been the subject of several research analyst reports. Citigroup Inc. lowered Becton Dickinson and from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $167.00 to $165.00 in a research report on Friday, September 23rd. Cowen and Company reaffirmed an “outperform” rating and issued a $185.00 target price on shares of Becton Dickinson and in a research report on Tuesday, August 16th. Jefferies Group reaffirmed a “buy” rating on shares of Becton Dickinson and in a research report on Friday, August 5th. Zacks Investment Research lowered Becton Dickinson and from a “buy” rating to a “hold” rating in a research report on Wednesday, November 16th. Finally, Leerink Swann reaffirmed a “market perform” rating and issued a $185.00 target price (up from $180.00) on shares of Becton Dickinson and in a research report on Monday. One analyst has rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $176.11.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.